misonidazole has been researched along with Esophageal Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (92.31) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glatstein, E; Makuch, RW; Schwade, JG; Strong, JM | 1 |
| Dar'ialova, SL; Kiseleva, ES | 1 |
| Ikeda, M; Irie, G; Kamata, R; Kaneda, K; Kikuchi, Y; Mikuriya, S; Mochizuki, S; Sakura, M; Sakurai, T; Watari, T | 1 |
| Mitsuhashi, N; Mogi, K; Nakajima, N; Niibe, H; Okazaki, A; Saito, K; Sakaino, K; Sudo, H; Suzuki, Y; Yonome, I | 1 |
| Abe, M; Dodo, Y; Ono, K; Takahashi, M | 1 |
| Asakawa, H; Hoshino, T; Watarai, J | 1 |
| Glatstein, E; Johnston, M; Kelly, B; Kinsella, TJ; Rowland, J; Schwade, JG | 1 |
| Bamberg, M; Scherer, E; Streffer, C; Tamulevicius, P | 2 |
| Moore, JL; Newman, H; Paterson, IC; Venables, S | 1 |
| Franko, AJ; Parliament, MB; Wiebe, LI | 1 |
| Hambraeus, GM; Lamm, IL; Landberg, T; Mercke, CE; Ranstam, J; Samuelsson, L; Willeń, R | 1 |
| Bamberg, M; Brust, V; Calcanis, A; Godehard, E; Herbst, M; Karstens, JH; Kleibel, F; Makoski, HB; Prignitz, R; Scherer, E | 1 |
1 review(s) available for misonidazole and Esophageal Neoplasms
| Article | Year |
|---|---|
[Electron acceptor compounds as radiation sensitizers of hypoxic cells in human tumors].
Topics: Brain Neoplasms; Combined Modality Therapy; Esophageal Neoplasms; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Metronidazole; Misonidazole; Mouth Neoplasms; Neoplasms; Radiation-Sensitizing Agents; Rectal Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms | 1984 |
6 trial(s) available for misonidazole and Esophageal Neoplasms
| Article | Year |
|---|---|
Dose-response curves for predicting misonidazole-induced peripheral neuropathy.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Esophageal Neoplasms; Half-Life; Humans; Injections, Intravenous; Kinetics; Metabolic Clearance Rate; Misonidazole; Nitroimidazoles; Osteosarcoma; Peripheral Nervous System Diseases; Probability | 1982 |
[Clinical evaluation of misonidazole combined with radiotherapy in the treatment of carcinoma of the esophagus--a double-blind randomized trial].
Topics: Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Misonidazole; Nitroimidazoles; Random Allocation | 1984 |
[Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
Topics: Aged; Esophageal Neoplasms; Female; Humans; Kidney; Lung Neoplasms; Male; Middle Aged; Misonidazole; Nitroimidazoles; Oxygen; Stomach Neoplasms; Tongue Neoplasms; Uterine Cervical Neoplasms | 1984 |
Clinical experience with intravenous misonidazole for carcinoma of the esophagus: results in attempting radiosensitization of each fraction of exposure.
Topics: Combined Modality Therapy; Esophageal Neoplasms; Humans; Injections, Intravenous; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1984 |
Misonidazole as a radiosensitizer in the radiotherapy of glioblastomas and oesophageal cancer. Pharmacokinetic and clinical studies.
Topics: Adult; Aged; Brain Neoplasms; Clinical Trials as Topic; Esophageal Neoplasms; Female; Glioma; Humans; Kinetics; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles | 1981 |
[Esophageal carcinoma: the final results of a multicenter and controlled German study with misonidazole and radiation].
Topics: Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Esophageal Neoplasms; Esophagus; Female; Humans; Male; Middle Aged; Misonidazole; Neoplasm Staging; Prospective Studies; Radiotherapy Dosage; Random Allocation | 1986 |
6 other study(ies) available for misonidazole and Esophageal Neoplasms
| Article | Year |
|---|---|
[Clinical evaluation of radiosensitizing effects of misonidazole].
Topics: Brain Neoplasms; Combined Modality Therapy; Drug Evaluation; Esophageal Neoplasms; Humans; Lung Neoplasms; Misonidazole; Nitroimidazoles | 1984 |
[Clinical study on radiotherapy in combination with misonidazole].
Topics: Aged; Esophageal Neoplasms; Female; Humans; Lung Neoplasms; Middle Aged; Misonidazole; Neoplasms; Nitroimidazoles; Pharyngeal Neoplasms; Radiation-Sensitizing Agents | 1983 |
[Clinical experiences with the radiosensitizer Misonidazol (author's transl)].
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Dexamethasone; Drug Interactions; Esophageal Neoplasms; Exanthema; Female; Glioma; Half-Life; Humans; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles; Phenytoin | 1981 |
Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Half-Life; Head and Neck Neoplasms; Humans; Kinetics; Misonidazole; Nitroimidazoles; Phenytoin; Time Factors | 1981 |
Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells.
Topics: Animals; Autoradiography; Cell Hypoxia; Dicumarol; Esophageal Neoplasms; Esophagus; Female; Male; Mice; Mice, Inbred BALB C; Misonidazole; Mucous Membrane; Muscle, Smooth; Tissue Distribution; Tumor Cells, Cultured | 1992 |
Prognostic factors influencing survival in combined radiotherapy and surgery of squamous cell carcinoma of the esophagus with special reference to a histopathologic grading system.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Humans; Misonidazole; Prognosis; Time Factors | 1988 |